Crossmark

Bispezifischer Antikörper für die dritte Therapielinie

Crossref DOI link: https://doi.org/10.1007/s15004-024-0791-y

Published Online: 2024-11-21

Published Print: 2024-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Sonnet, Miriam
License Information

Text and Data Mining valid from 2024-11-01

Version of Record valid from 2024-11-01
More Information

Article History

First Online: 21 November 2024

Free to read: This content has been made available to all.